Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001179110-13-011355)

Filing Details

Accession Number:
0001179110-13-011355
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-02 18:53:47
Reporting Period:
2013-07-01
Filing Date:
2013-07-02
Accepted Time:
2013-07-02 18:53:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012140 Onyx Pharmaceuticals Inc ONXX Biological Products, (No Disgnostic Substances) (2836) 943154463
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1182467 H Corinne Nevinny C/O Onyx Pharmaceuticals, Inc.
249 E. Grand Ave.
South San Francisco CA 94080		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-07-01 2,000 $132.63 6,600 No 4 S Direct
Common Stock Disposition 2013-07-01 3,000 $132.63 3,600 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares sold pursuant to 10b5-1 plan.